Swiss GO Trial Group
- Address
- Spitalstrasse 21
Sponsor Overview
Specializations
Gynecologic Oncology
Research activity is centered on epithelial ovarian cancer, with attention to treatment strategies used after initial surgery and chemotherapy. The clinical focus includes disease control in women with ovarian malignancy and the evaluation of ongoing management approaches in the post-treatment setting.
- Ovarian cancer
- Post-treatment maintenance therapy
- Recurrence prevention
The sponsor’s network spans multiple collaborating sites across more than one country, supporting research in gynecologic cancer care and treatment optimization.
Hormone-Responsive Cancer Therapy
Its therapeutic interest includes the use of aromatase inhibitor therapy in a hormone-sensitive malignancy, reflecting a focus on endocrine-based management for ovarian cancer. This area links cancer biology with targeted hormonal treatment in the maintenance setting.
- Endocrine therapy
- Letrozole
- Aromatase inhibition
Research in this domain is directed toward maintaining disease control after standard frontline treatment.
Oncology Outcomes
The sponsor’s trial activity is aligned with clinical outcomes assessment in progression-free survival and other measures of disease stability. This places emphasis on how maintenance treatment influences the course of ovarian cancer over time.
- Progression-free survival
- Disease stabilization
- Clinical effectiveness
These interests support evaluation of long-term disease management in a setting where sustained control is clinically important.
Multicentre Clinical Research
With a broad collaborative structure involving numerous research sites, the sponsor is active in coordinated studies across Switzerland and another participating country. Its research profile includes the organization of multicentre oncology trials in specialist care settings.
- Collaborative research sites
- Cross-border clinical research
- Specialist oncology networks
This activity supports the study of ovarian cancer treatment within a distributed clinical research environment.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase III Randomized Double-Blind Placebo-Controlled Trial of Letrozole Maintenance Therapy in Epithelial Ovarian Cancer Post-Surgery and Chemotherapy |  Austria Germany | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 31 sites across their trial portfolio.
Therapeutic Focus
- 1.Female Urogenital Diseases and Pregnancy Complications1 trial142 other sponsors
Partnered Research Centres
31 centres- Address
- Hohe Weide 17, Eimsbuettel, 20259 Hamburg
- Address
- Langenbeckstrasse 1, Oberstadt, 55131 Mainz
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Perlasberger Strasse 41, 94469 Deggendorf
- Address
- Am Bahnhofsplatz 5, 31134 Hildesheim
- Address
- Ludwig-Erhard-Strasse 100, Dotzheim, 65199 Wiesbaden
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Swiss GO Trial Group.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.